Tuttle Capital AI Drug Discovery ETF

529900CD9SMLQYNL7S35

The entity

Status: Active
LEI status: Issued and current
Category: Fund
Legal form: Statutory Trust (4FSX)
Jurisdiction: US-DE
Entity created: July 17, 2026

Address

Country: United States
Legal address: c/o THE CORPORATION TRUST COMPANY,CORPORATION TRUST CENTER,1209 ORANGE ST19801 WILMINGTONUnited States (US-DE)
Head office: c/o Tuttle Capital Management, LLC, c/o BUSINESS FILINGS INCORPORATED,108 WEST 13TH ST19801 WILMINGTONUnited States (US-DE)

Identifier

LEI: 529900CD9SMLQYNL7S35
Registered: September 8, 2026 at 09:50 AM UTC
Last updated: September 8, 2026 at 09:50 AM UTC
Next renewal: September 8, 2027 at 09:50 AM UTC
Issuer: WM Datenservice (5299000J2N45DDNE4Y28)
Registered with: EDGAR (RA000665)
Identifier: S000109573
Verified against: EDGAR (RA000665)
Verified as: S000109573
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owned by

TUTTLE CAPITAL MANAGEMENT, LLC
Fund managerUnited States9845000D509661HOF540
Managed Portfolio Series
Umbrella fundUnited States254900SQ3GG01NP4WM65

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/529900CD9SMLQYNL7S35This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search